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To the Editor,
So far, little attention has been paid to the link between
immunosenescence and the dramatic mortality rate of
coronavirus disease 2019 (COVID-19) in older age
groups. Indeed, the number of cases of COVID-19, caused
by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), is very low among children and teenagers,
in contrast to the increased frequency in adults and the
elderly, who are also more at risk of developing very
serious symptoms and death (Guan et al. 2020; Wu and
McGoogan 2020). As shown in Fig. 1, a similar epidemi-
ological profile was observed during previous coronavirus
(severe acute respiratory syndrome coronavirus 1, SARS-
CoV-1, andMiddle east respiratory syndrome coronavirus,
MERS-CoV) outbreaks (Jia et al. 2009; Salamatbakhsh
et al. 2019). Notably, the same trend was also noted during
West Nile virus and, with some exceptions in very young
children, Ebolavirus outbreaks (Bower et al. 2016; Hayes
et al. 2005). Likely this phenomenon is multifactorial. For
instance, in elderly individuals with severe COVID-19,
associated comorbidities are much more prevalent (Guan
et al. 2020). In addition, the progressive accumulation of
senescent cells during life may play a role in the vulnera-
bility of old people to COVID-19, resulting in reduced
functionality of the organs, such as the lungs, and facilitat-
ing conditions for the development of fibrosis. Moreover,
senescent cells can generate a pro-inflammatory environ-
ment, referred to as SASP (for senescence-associated se-
cretory phenotype), which includes many inflammatory
cytokines (e.g., interleukin-6) and contributes to the basal
hyperinflammatory status characteristic of the old person.
This hyperinflammatory status might influence the expres-
sion of ACE2, CD147, cyclophilins, CD26, and other
CoV-associated molecules in human tissues, thus favoring
viral entry (Radzikowska et al. 2020). It likely also consti-
tutes an already unbalanced pro-inflammatory back-
ground, on which the development of an exacerbated
inflammatory response and acute respiratory distress syn-
drome may be facilitated upon SARS-CoV-2 infection.
An undoubtedly common important factor for the rapid
spread of these viruses is that they are emerging pathogens
introduced from scratch into the human population never
previously exposed to them. The induction of de novo
immune responses against such viruses relies on their
recognition by naïve, and not memory, T cells. Since, the
pool of naïve T cells decreases with age, reaching very low
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numbers in the elderly (Briceno et al. 2016), we believe
that this may contribute to the age-dependent development
of the disease and to the greater severity of symptoms and
death in the elderly, characterizing these emerging
infections.
Indeed, several pieces of evidence highlight the impor-
tance of T cell responses for CoV control. Results from
murinemodels show that virus-specific CD4+ and CD8+ T
cells are essential for CoV clearance (Chen et al. 2010;
Zhao et al. 2010), which is, instead, delayed in mice
lacking T cells or in old animals experiencing an age-
dependent decrease of virus-specific CD8+ T cells (Chen
et al. 2010; Zhao et al. 2014; Zhao et al. 2011). The
appearance of interferon (IFN)-γ secreting CD4+ and
CD8+ T cells specific for the structural proteins of CoV
has been observed in the lungs of infected mice and is
associated with viral clearance (Chen et al. 2010; Zhao
et al. 2009). Lung-infiltrating CoV-specific CD8+ T cells
display high cytotoxic potential (Zhao et al. 2010; Zhao
et al. 2009), while depletion of CD4+ T cells results in a
diminished neutralizing antibody response along with
higher viral titers in the lungs (Chen et al. 2010). Together,
these data suggest that CD8+ T cells are important for the
killing of CoV-infected cells and CD4+ T cells play a key
role in the support of CoV-specific antibody responses and
in the cell recruitment in the lung (Chen et al. 2010; Zhao
et al. 2010; Zhao et al. 2009).
In humans, MERS-CoV, SARS-CoV-1, and SARS-
CoV-2-infected patients with severe manifestations exhibit
a pronounced T cell loss (Jiang et al. 2020; Li et al. 2004;
Liu et al. 2020;Min et al. 2016; Qin et al. 2020;Wang et al.
2020; Wu et al. 2020) and CD4+ and CD8+ T cell numbers
negatively correlate with the levels of pro-inflammatory
cytokines associated with worst prognosis (Diao et al.
2020). Importantly, T cell count normalization coincides
with the improvement of clinical conditions (Diao et al.
2020; Gu et al. 2005; Li et al. 2004). It has also recently
been shown that activated effector CD4+ and CD8+ T cells
appear in the blood of COVID-19 subjects a few days after
the development of symptoms and precede their resolution,
likely contributing to the infection clearance (Thevarajan
et al. 2020). Moreover, the amount of virus-specific CD4+
T cells directly correlates with humoral responses (Grifoni
et al. 2020; Ni et al. 2020), and a larger proportion of tissue-
resident CD8+ T cells with effector potential has been
reported in the bronchoalveolar lavage fluids of patients
with moderate infection compared with severely ill subjects
(Liao et al. 2020), whose circulating T cells are instead
characterized by high expression of inhibitory checkpoints
(Diao et al. 2020).
Naïve T cells represent the primary source to mount a
necessary adaptive immune response against emerging vi-
ruses, such asCoV.However, the quantity of naïveT cells is
progressively reduced and lymphopoiesis compromised
with old age, due to thymic involution as well as defects
of the lymphopoietic progenitors (Fali et al. 2018). The
reduced naïve T cell pool may affect the global TCR
repertoire and its diversity, and thus the capacity of an old
immune system to detect neoantigens. Moreover, elderly
people show a decreased number of naïve T cells, and the
intrinsic properties and capacity of these cells to be activated
and to differentiate are affected (Fali et al. 2019; Li et al.
2012). As a consequence, old individuals present with
reduced priming capacity and impaired responses against
neoantigens (Briceno et al. 2016; Nikolich-Zugich 2014). In
addition, some of the comorbidities associated with aging
are characterized by low naïve T cell frequencies (Rattik
et al. 2019) and bymetabolic alterations whichmay, in turn,
negatively affect T cell metabolism and functionality (Nicoli
et al. 2018). Overall, these observations indicate that suc-
cessful generation of primary responses against novel virus-
es from the naïveT cell pool is compromisedwith aging and
associated comorbidities, likely contributing to the age-
related severity of emerging infections, such as that caused
by SARS-CoV-2.
It is however important to highlight that the protection
conferred by functional epitope-specific T cells should not
be confused with the hyperactivation of the immune sys-
tem that accounts for the severe tissue immune injury in
COVID-19 patients with fatal prognosis. This detrimental
inflammatory process, which is a further hallmark of aging,
is the likely consequence of innate immune mechanisms.
Although a high proportion of hyperactivated T cells have
been found in COVID-19 subjects, the plasmatic cytokine
profile, but not the T cell activation levels, distinguished
between non-severe and severe SARS-CoV-2-infected
subjects (Qin et al. 2020). Considering the relatively high
median age of these patients, it is reasonable to speculate
the presence of a low number of epitope-specific naïve T
cells that could be primed. This suggests that most T
lymphocytes infiltrating the lungs are not virus-specific
but potentially harmful. If confirmed, this scenario would
resemble that of other infections, such as HIV, where
disease progression, although directly related with T cell
hyperactivation, is inversely related with the number and
functions of virus-specific T cells (Appay and Sauce 2008;
Nicoli et al. 2016).
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We think that the preservation of the naïve T cell pool
and de novo T cell responsiveness may thus constitute a
future priority to be addressed by researchers for the
development of preventive strategies against emerging
infections. Also, the enhancement of virus-specific T
cell responses by immunotherapeutics avoiding unspe-
cific activation and inflammation may be important in
already infected patients before the onset of severe
symptoms to prevent disease exacerbation and promote
viral clearance. Finally, the activation of T cell re-
sponses, which have been shown to be long-lasting after
SARS-CoV-1 and MERS-CoV infections, should also
be considered in the development of vaccines against
COVID-19. However, frail and elderly subjects have
poor post-vaccination immune responses. For this rea-
son, a great attention should be paid to mechanisms that
impair SARS-CoV-2-specific immune responses, as the
same mechanisms could negatively affect the effective-
ness of future COVID-19 vaccines in these populations.
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Fig. 1 Age-distribution of numbers of cases and deaths during
coronavirus outbreaks and age-associated changes in immune
profile. The age range for COVID-19 (Italy and China) andMERS
is different from that of SARS due to a different aggregation in
source datasets. Data for COVID Italy are from the COVID-19
Task Force of the Department of Infectious Diseases and the IT
Service Istituto Superiore di Sanità, update of April 13, 2020; data
for COVID China are from Wu et al. 2020; data for SARS China
are from Jia et al. 2009; data for MERS global are from
Salamatbakhsh et al. 2019
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